Market Place
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Please Wait
Applying Filters...
01 4sanofi-aventis Canada Inc.
02 3Abbott Laboratories Limited
03 1PENDOPHARM, Division of Pharmascience Inc.
04 2Blank
01 21262005
02 32036089
03 12362769
04 42436275
01 1LEUPROLIDE ACETATE
02 7Leuprolide Acetate
03 2Blank
01 1POWDER FOR SUSPENSION
02 3Powder for Injection
03 3Powder for Suspension, Sustained-Release
04 1Solution for Injection
05 2Blank
01 22006-09-26
02 32011-02-11
03 12020-12-15
04 42021-09-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Brand Name : ELIGARD
Patent Number : 2436275
Filing Date : 2001-09-21
Strength per Unit : 7.5mg
Dosage Form : Solution for Injection
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Brand Name : ELIGARD
Patent Number : 2436275
Filing Date : 2001-09-21
Strength per Unit : 22.5 mg / syringe
Dosage Form : Powder for Suspension, Sustained-Release
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Brand Name : ELIGARD
Patent Number : 2436275
Filing Date : 2001-09-21
Strength per Unit : 30 mg / syringe
Dosage Form : Powder for Suspension, Sustained-Release
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Brand Name : ELIGARD
Patent Number : 2436275
Filing Date : 2001-09-21
Strength per Unit : 45 mg / syringe
Dosage Form : Powder for Suspension, Sustained-Release
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-09-21
Date Granted : 2007-01-02
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Brand Name : LUPRON DEPOT
Patent Number : 2036089
Filing Date : 1991-02-11
Strength per Unit : 30 mg
Dosage Form : Powder for Injection
Human Or VET : Human
Route of Administration : Intramuscular
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Brand Name : LUPRON DEPOT
Patent Number : 2036089
Filing Date : 1991-02-11
Strength per Unit : 11.25mg
Dosage Form : Powder for Injection
Human Or VET : Human
Route of Administration : Intramuscular
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Brand Name : LUPRON DEPOT
Patent Number : 2036089
Filing Date : 1991-02-11
Strength per Unit : 22.5mg
Dosage Form : Powder for Injection
Human Or VET : Human
Route of Administration : Intramuscular
Patent Expiration Date : 2011-02-11
Date Granted : 2000-12-05
Patent Expiration Date : 2020-12-15
Date Granted : 2008-09-09
Brand Name : ZEULIDE DEPOT
Patent Number : 2362769
Filing Date : 2000-12-15
Strength per Unit : 3.75 mg
Dosage Form : POWDER FOR SUSPENSION
Human Or VET : Human
Route of Administration : INTRAMUSCULAR
Patent Expiration Date : 2020-12-15
Date Granted : 2008-09-09
Patent Expiration Date : 2006-09-26
Date Granted :
Brand Name :
Patent Number : 1262005
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2006-09-26
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2006-09-26
Date Granted :
Brand Name :
Patent Number : 1262005
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2006-09-26
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
